BCR and mantle cell lymphoma: Looking ahead to the possibility of a combination approach, ponatinib, an inhibitor of BCR-ABL and KIT, and midostaurin inhibited cell growth and induced apoptosis in the human MCL cell line HMC-1 when administered together (55).